Blab Business
Axuall Adds Former Optum Executive Kris Joshi to Board as It Expands AI-Driven Provider Data Platform
On September 9 2026, Cleveland‑based clinical workforce intelligence firm Axuall announced that Dr. Kris Joshi, PhD, will join its Board of Directors as an independent director. The appointment signals the company’s intent to broaden its AI‑powered provider‑data services.
Joshi comes to Axuall at a time when health‑care organizations grapple with the dual challenge of expanding clinical capacity and reconciling fragmented, antiquated workforce data. Axuall’s platform supplies verified provider information, integrates seamlessly into existing workflows, and harnesses AI to deliver real‑time insights that drive patient access through smarter planning, recruiting, onboarding, and network alignment.
The press release notes that Joshi’s career mirrors the evolution Axuall is pursuing. He previously headed Optum’s $3 billion Software, Network, and Data division following Optum’s 2022 acquisition of Change Healthcare. In that capacity he steered a portfolio that spanned software, data, analytics, payment, and network services for payers, providers, and life‑science firms. Before Optum, he led Norstella, a global life‑sciences data and AI company.
Joshi’s earlier tenure at Change Healthcare lasted nine years, during which he served as EVP and President of Software and Network Solutions. Under his leadership, the company’s revenue surged from $1 billion to $3.5 billion and it completed a successful IPO. Prior to that, he held senior strategy positions at IBM’s global health‑care unit and as Global Vice President of Products at Oracle, where he helped launch the Health Sciences Global Business Unit.
Joshi earned a bachelor’s degree in mathematics from Caltech and a PhD in astrophysics from MIT.
"Kris brings a wealth of perspective and insight as we expand our capabilities and markets," said Charlie Lougheed, founder and CEO of Axuall. "He has run some of the largest data and network businesses in healthcare, and he understands that the hard part is not the model; it is the quality and reach of the data underneath it. His judgment on where enterprise healthcare is heading, and how AI changes healthcare workforce decisions, is already shaping how we think about the next phase of the company."
"Provider data has been treated as a back‑office cost for decades, and that is changing fast. The organizations that can answer workforce questions accurately and contextually using AI will be able to move faster. Axuall has assembled the underlying enterprise‑grade platform that makes those answers possible, and I am glad to help the team turn it into a standard the industry relies on."
Axuall’s strategy now centers on an agent‑forward product model that uses AI to deliver comprehensive, actionable answers about clinician supply, credentialing readiness, and network alignment. The company maintains that verified, continuously refreshed provider data is the foundation for this shift.
The firm’s flagship offering, Axuall Sync, operates as an always‑on data backbone that keeps provider information accurate, complete, and current across systems such as Epic SER, data‑management platforms, directories, and scheduling tools. By transforming static provider data into real‑time insights, Axuall claims to accelerate recruitment, onboarding, and counter provider data decay, thereby expanding patient access.
Axuall’s website notes that its solutions are used by health‑care organizations to recruit, manage, and scale their clinical workforce. The company’s focus on AI‑driven intelligence aligns with broader industry trends toward data‑centric workforce planning.
The board appointment follows Axuall’s recent Series B funding round, which closed at $20 million led by Noro‑Moseley Partners, and the company’s earlier $10.4 million Series A round in July 2026. The firm has also attracted investment from a range of health‑care organizations.
As Axuall continues to roll out its AI‑enhanced platform, the addition of Joshi to its board signals a commitment to leveraging deep expertise in large‑scale data and AI to address persistent gaps in provider information. The company’s next steps will likely involve expanding its product suite, deepening integration with clinical systems, and pursuing additional funding or strategic partnerships.
The appointment is effective immediately and will be reflected in Axuall’s upcoming governance filings. The company has not announced any immediate changes to its executive team.
The press release also noted that Axuall’s website provides further details on its data and AI solutions, and that the company remains headquartered in Cleveland, Ohio.
For more information, the company’s media contact is Madison Lander, reachable at 1‑779‑225‑5027 or madison.lander@axuall.com.
Joshi comes to Axuall at a time when health‑care organizations grapple with the dual challenge of expanding clinical capacity and reconciling fragmented, antiquated workforce data. Axuall’s platform supplies verified provider information, integrates seamlessly into existing workflows, and harnesses AI to deliver real‑time insights that drive patient access through smarter planning, recruiting, onboarding, and network alignment.
The press release notes that Joshi’s career mirrors the evolution Axuall is pursuing. He previously headed Optum’s $3 billion Software, Network, and Data division following Optum’s 2022 acquisition of Change Healthcare. In that capacity he steered a portfolio that spanned software, data, analytics, payment, and network services for payers, providers, and life‑science firms. Before Optum, he led Norstella, a global life‑sciences data and AI company.
Joshi’s earlier tenure at Change Healthcare lasted nine years, during which he served as EVP and President of Software and Network Solutions. Under his leadership, the company’s revenue surged from $1 billion to $3.5 billion and it completed a successful IPO. Prior to that, he held senior strategy positions at IBM’s global health‑care unit and as Global Vice President of Products at Oracle, where he helped launch the Health Sciences Global Business Unit.
Joshi earned a bachelor’s degree in mathematics from Caltech and a PhD in astrophysics from MIT.
"Kris brings a wealth of perspective and insight as we expand our capabilities and markets," said Charlie Lougheed, founder and CEO of Axuall. "He has run some of the largest data and network businesses in healthcare, and he understands that the hard part is not the model; it is the quality and reach of the data underneath it. His judgment on where enterprise healthcare is heading, and how AI changes healthcare workforce decisions, is already shaping how we think about the next phase of the company."
"Provider data has been treated as a back‑office cost for decades, and that is changing fast. The organizations that can answer workforce questions accurately and contextually using AI will be able to move faster. Axuall has assembled the underlying enterprise‑grade platform that makes those answers possible, and I am glad to help the team turn it into a standard the industry relies on."
Axuall’s strategy now centers on an agent‑forward product model that uses AI to deliver comprehensive, actionable answers about clinician supply, credentialing readiness, and network alignment. The company maintains that verified, continuously refreshed provider data is the foundation for this shift.
The firm’s flagship offering, Axuall Sync, operates as an always‑on data backbone that keeps provider information accurate, complete, and current across systems such as Epic SER, data‑management platforms, directories, and scheduling tools. By transforming static provider data into real‑time insights, Axuall claims to accelerate recruitment, onboarding, and counter provider data decay, thereby expanding patient access.
Axuall’s website notes that its solutions are used by health‑care organizations to recruit, manage, and scale their clinical workforce. The company’s focus on AI‑driven intelligence aligns with broader industry trends toward data‑centric workforce planning.
The board appointment follows Axuall’s recent Series B funding round, which closed at $20 million led by Noro‑Moseley Partners, and the company’s earlier $10.4 million Series A round in July 2026. The firm has also attracted investment from a range of health‑care organizations.
As Axuall continues to roll out its AI‑enhanced platform, the addition of Joshi to its board signals a commitment to leveraging deep expertise in large‑scale data and AI to address persistent gaps in provider information. The company’s next steps will likely involve expanding its product suite, deepening integration with clinical systems, and pursuing additional funding or strategic partnerships.
The appointment is effective immediately and will be reflected in Axuall’s upcoming governance filings. The company has not announced any immediate changes to its executive team.
The press release also noted that Axuall’s website provides further details on its data and AI solutions, and that the company remains headquartered in Cleveland, Ohio.
For more information, the company’s media contact is Madison Lander, reachable at 1‑779‑225‑5027 or madison.lander@axuall.com.
